Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.72
(1.44%)
CNY 12.72
(1.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.94 Billion CNY | 39.99% |
| 2022 | 3.53 Billion CNY | 1.16% |
| 2021 | 3.49 Billion CNY | 30.66% |
| 2020 | 2.67 Billion CNY | 32.26% |
| 2019 | 2.02 Billion CNY | 29.79% |
| 2018 | 1.55 Billion CNY | 40.18% |
| 2017 | 1.11 Billion CNY | 58.64% |
| 2016 | 700.5 Million CNY | 16.62% |
| 2015 | 600.67 Million CNY | 39.9% |
| 2014 | 429.35 Million CNY | 34.0% |
| 2013 | 320.41 Million CNY | 26.94% |
| 2012 | 252.4 Million CNY | 4.18% |
| 2011 | 242.27 Million CNY | 41.7% |
| 2010 | 170.97 Million CNY | 38.54% |
| 2009 | 123.4 Million CNY | 70.19% |
| 2008 | 72.51 Million CNY | 46.98% |
| 2007 | 49.33 Million CNY | 175.73% |
| 2006 | 17.89 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.23 Billion CNY | 144.09% |
| 2024 Q2 | 1.25 Billion CNY | 1.93% |
| 2024 Q3 | 1.72 Billion CNY | 37.49% |
| 2023 FY | 4.94 Billion CNY | 39.99% |
| 2023 Q3 | 1.92 Billion CNY | 40.28% |
| 2023 Q4 | 505.3 Million CNY | -73.69% |
| 2023 Q2 | 1.36 Billion CNY | 18.67% |
| 2023 Q1 | 1.15 Billion CNY | 795.4% |
| 2022 Q3 | 1.47 Billion CNY | 43.9% |
| 2022 FY | 3.53 Billion CNY | 1.16% |
| 2022 Q1 | 908.09 Million CNY | 93.83% |
| 2022 Q2 | 1.02 Billion CNY | 12.76% |
| 2022 Q4 | 128.82 Million CNY | -91.26% |
| 2021 Q3 | 1.28 Billion CNY | 35.11% |
| 2021 Q2 | 951.74 Million CNY | 20.8% |
| 2021 Q1 | 787.86 Million CNY | 90.96% |
| 2021 FY | 3.49 Billion CNY | 30.66% |
| 2021 Q4 | 468.49 Million CNY | -63.57% |
| 2020 Q2 | 788.2 Million CNY | 498.33% |
| 2020 Q3 | 1.34 Billion CNY | 70.22% |
| 2020 Q4 | 412.57 Million CNY | -69.25% |
| 2020 FY | 2.67 Billion CNY | 32.26% |
| 2020 Q1 | 131.73 Million CNY | -44.56% |
| 2019 Q3 | 749.77 Million CNY | 29.07% |
| 2019 Q1 | 453.54 Million CNY | 94.57% |
| 2019 FY | 2.02 Billion CNY | 29.79% |
| 2019 Q4 | 237.59 Million CNY | -68.31% |
| 2019 Q2 | 580.92 Million CNY | 28.08% |
| 2018 Q1 | 331.53 Million CNY | 61.93% |
| 2018 Q3 | 554.53 Million CNY | 26.44% |
| 2018 Q4 | 233.1 Million CNY | -57.96% |
| 2018 FY | 1.55 Billion CNY | 40.18% |
| 2018 Q2 | 438.56 Million CNY | 32.28% |
| 2017 Q3 | 404.72 Million CNY | 38.68% |
| 2017 Q4 | 204.74 Million CNY | -49.41% |
| 2017 FY | 1.11 Billion CNY | 58.64% |
| 2017 Q1 | 209.96 Million CNY | 128.15% |
| 2017 Q2 | 291.83 Million CNY | 38.99% |
| 2016 FY | 700.5 Million CNY | 16.62% |
| 2016 Q1 | 163.6 Million CNY | 59.52% |
| 2016 Q2 | 193.82 Million CNY | 18.47% |
| 2016 Q3 | 251.04 Million CNY | 29.52% |
| 2016 Q4 | 92.02 Million CNY | -63.34% |
| 2015 Q4 | 102.55 Million CNY | -52.58% |
| 2015 Q3 | 216.25 Million CNY | 34.23% |
| 2015 Q2 | 161.11 Million CNY | 33.43% |
| 2015 Q1 | 120.74 Million CNY | 60.38% |
| 2015 FY | 600.67 Million CNY | 39.9% |
| 2014 Q2 | 110.24 Million CNY | 21.82% |
| 2014 FY | 429.35 Million CNY | 34.0% |
| 2014 Q4 | 75.28 Million CNY | -50.9% |
| 2014 Q3 | 153.32 Million CNY | 39.07% |
| 2014 Q1 | 90.49 Million CNY | 48.37% |
| 2013 Q4 | 60.99 Million CNY | -48.86% |
| 2013 FY | 320.41 Million CNY | 26.94% |
| 2013 Q1 | 66.78 Million CNY | 8.95% |
| 2013 Q2 | 73.35 Million CNY | 9.85% |
| 2013 Q3 | 119.28 Million CNY | 62.61% |
| 2012 Q1 | 66.49 Million CNY | 26.56% |
| 2012 Q4 | 61.29 Million CNY | -17.11% |
| 2012 Q3 | 73.94 Million CNY | 45.97% |
| 2012 Q2 | 50.66 Million CNY | -23.81% |
| 2012 FY | 252.4 Million CNY | 4.18% |
| 2011 Q3 | 75.84 Million CNY | 21.42% |
| 2011 Q1 | 51.42 Million CNY | 13.23% |
| 2011 Q2 | 62.46 Million CNY | 21.46% |
| 2011 Q4 | 52.54 Million CNY | -30.73% |
| 2011 FY | 242.27 Million CNY | 41.7% |
| 2010 FY | 170.97 Million CNY | 38.54% |
| 2010 Q2 | 37.19 Million CNY | 4.34% |
| 2010 Q1 | 35.64 Million CNY | 21.45% |
| 2010 Q3 | 52.72 Million CNY | 41.76% |
| 2010 Q4 | 45.41 Million CNY | -13.86% |
| 2009 Q1 | 20.67 Million CNY | 59.36% |
| 2009 FY | 123.4 Million CNY | 70.19% |
| 2009 Q4 | 29.34 Million CNY | -23.78% |
| 2009 Q3 | 38.5 Million CNY | 10.41% |
| 2009 Q2 | 34.87 Million CNY | 68.66% |
| 2008 FY | 72.51 Million CNY | 46.98% |
| 2008 Q3 | 27.98 Million CNY | 0.0% |
| 2008 Q4 | 12.97 Million CNY | -53.64% |
| 2007 FY | 49.33 Million CNY | 175.73% |
| 2006 FY | 17.89 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 1 Billion CNY | -391.309% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 1.21 Billion CNY | -306.938% |